Implanet offers to buy majority stake in medtech company

Boston-based medical technology company Implanet has received approval from its founding shareholders to acquire a majority stake in French implant manufacturer Orthopaedic & Spine Development, the company reported March 17. 

Advertisement

Implanet specializes in vertebral and knee surgery implants. OSD manufactures, develops and markets spinal implants. The acquisition aims to strengthen Implanet’s position in the spine market, according to the company. 

OSD is valued at just over $5 million. OSD’s founding shareholders, representing 71.5 percent of the capital, have responded favorably to the offer. A shareholder agreement to submit the acquisition will be convened before March 31.

More articles on physicians:
There were 226 ASCs opened in 2019 & 3 more MedPAC 2021 report highlights
ENT specialists join Florida physician group
Bundled payments in ASCs: Good business or a race to the bottom?

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.